Induction of cytokines in glial cells surrounding cortical β-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology

International Journal of Developmental Neuroscience

Volumn 18, Issue 4-5, 2000, Pages 423-431

  Mehlhorn, Gaby ^a   Hollborn, Margrit ^a   Schliebs, Reinhard ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Amyloid plaque; Alzheimer's disease; Cytokines; Interleukins; Neuroinflammation; Reactive astrocytes; Transgenic mouse

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; MACROPHAGE CHEMOTACTIC FACTOR; MACROPHAGE MIGRATION INHIBITION FACTOR;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GLIA CELL; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; NEUROGENIC INFLAMMATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RIBONUCLEASE PROTECTION ASSAY; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; CEREBRAL CORTEX; CYTOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION; HUMANS; IN SITU HYBRIDIZATION; INTERFERON TYPE II; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-18; INTERLEUKIN-6; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MICE; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; NEURITIS; NEUROGLIA; RNA, MESSENGER; SENILE PLAQUES; SIALOGLYCOPROTEINS;

EID: 0034237388     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-5748(00)00012-5     Document Type: Article

References (30)

1. Abraham C.R., Shirahama T., Potter H. α1-Antichymotrypsin is associated solely with amyloid deposits containing the β-protein. Amyloid and cell localization of α1-antichymotrypsin. Neurobiol. Aging. 11:1990;123-129.
2. Apelt J., Schliebs R., Beck M., Roßner S., Bigl V. Expression of amyloid precursor protein mRNA isoforms in rat brain is differentially regulated during postnatal maturation and by cholinergic activity. Int. J. Devl. Neurosci. 15:1997;95-112.
3. Bauer J., Strauss S., Schreiter-Gasser U., Ganter U., Schlegel P., Witt I., Volk B., Berger M. Interleukin-6 and α2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. FEBS Lett. 285:1991;111-114.
4. Breitner J.C. Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: a current appraisal. Neurobiol. Aging. 17:1996;789-794.
5. Breitner J.C. The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease. Annu. Rev. Med. 47:1996;401-411.
6. Cotter R.L., Burke W.J., Thomas V.S., Potter J.F., Zheng J., Gendelman H.E. Insights into the neurodegenerative process of Alzheimer's disease: a role for mononuclear phagocyte-associated inflammation and neurotoxicity. J. Leukoc. Biol. 65:1999;416-427.
7. Dickson D.W., Lee S.C., Mattiace L.A., Yen S.H., Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia. 7:1993;75-83.
8. Eikelenboom P., Hack C.E., Rozemuller J.M., Stam F.C. Complement activation in amyloid plaques in Alzheimer's dementia. Virchow Arch. B Cell Pathol. 56:1989;259-262.
9. Eikelenboom P., Zhan S.S., Kamphorst W., van der Valk P., Rozemuller J.M. Cellular and substrate adhesion molecules (integrins) and their ligands in cerebral amyloid plaques in Alzheimer's disease. Virchows Arch. 424:1994;421-427.
10. Gonzalez-Scarano F., Baltuch G. Microglia as mediators of inflammatory and degenerative diseases. Annu. Rev. Neurosci. 22:1999;219-240.
11. Graber H.U., Zurbriggen A., Vandevelde M. Identification of canine glial cells by nonradioactive in situ hybridization. J. Vet. Med. A. 40:1993;665-671.
12. Griffin W.S.T., Stanley L., Ling C., White L., MacLeod V., Perrot L.J., White C.L., Zraoz C. Brain interleukin-1 and S-100 immunoreactivity are elevated in Down's syndrome and Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 86:1989;7611-7615.
13. Haga S., Akai K., Ishii T. Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain. An immunohistochemical study using a novel monoclonal antibody. Acta Neuropathol. (Berl.). 77:1989;569-575.
14. Hartlage-Rübsamen M., Lemke R., Schliebs R. Interleukin-1β, inducible nitric oxide synthase, and nuclear factor-κB are induced in morphologically distinct microglia after rat hippocampal lipopolysaccharide/interferon-γ injection. J. Neurosci. Res. 57:1999;388-398.
15. Hsiao K., Borchelt D.R., Olson K., Johannsdottir R., Kitt C., Yunis W., Xu S., Eckman C., Younkin S., Price D., Iadecola C., Brent, Clark H., Carlson G. Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor protein. Neuron. 15:1995;1203-1218.
16. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Aβ elevation and amyloid plaques in transgenic mice. Science. 274:1996;99-102.
17. Hüll M., Strauss S., Volk B., Berger M., Bauer J. Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients. Acta Neuropathol. 89:1995;544-551.
18. Hüll M., Fiebich B.L., Lieb K., Strauss S., Berger S.S., Volk B., Bauer J. Interleukin-6-associated inflammatory processes in Alzheimer's disease: new therapeutic options. Neurobiol. Aging. 17:1996;795-800.
19. Irizarry M.C., McNamara M., Fedorchak K., Hsiao K., Hyman B.T. APPSW transgenic mice develop age-related Aβ deposits and neuropil abnormalities, but no neuronal loss in CA1. J. Neuropath. Exp. Neurol. 56:1997;965-973.
20. Itagaki S., McGeer P.L., Akiyama H., Zhu S., Selkoe D. Relationship of microglia and astrocytes to amyloid deposity of Alzheimer's disease. J. Neuroimmunol. 24:1989;173-182.
21. Johnstone M., Gearing A.J., Miller K.M. A central role for astrocytes in the inflammatory response to β-amyloid; chemokines, cytokines and reactive oxygen species are produced. J. Neuroimmunol. 93:1999;182-193.
22. Lemke R., Hartlage-Rübsamen M., Schliebs R. Differential injury-dependent glial expression of interleukins-1α,β, and interleukin-6 in rat brain. Glia. 27:1999;75-87.
23. McGeer P.L., Kawamata T., Walker D.G., Akiyama H., Tooyama T., McGeer E.G. Microglia in degenerative neurological disease. Glia. 7:1993;84-92.
24. McGeer P.L., McGeer E.G. The inflammatory response system of brain: implications for therapy and other neurodegenerative diseases. Brain Res. Rev. 21:1995;195-218.
25. McGeer P.L., McGeer E.G. Inflammation of the brain in Alzheimer's disease: implications for therapy. J. Leukoc. Biol. 65:1999;409-415.
26. Pappolla M.A., Chyan Y.-J., Omar R.A., Hsiao K., Perry G., Smith M.A., Bozner P. Evidence of oxidative stress and in vivo neurotoxicity of β-amyloid in a transgenic mouse model of Alzheimer's disease. Am. J. Pathol. 152:1998;871-877.
27. Smith M.A., Hirai K., Hsiao K., Pappolla M.A., Harris P.L.R., Siedlak S.L., Tabaton M., Perry G. Amyloid-β deposition in Alzheimer transgenic mice is associated with oxidative stress. J. Neurochem. 70:1998;2212-2215.
28. Solá C., Mengod G., Probst A., Palacios J.M. Differential regional and cellular distribution of β-amyloid precursor protein messenger RNAs containing and lacking the Kunitz protease inhibitor domain in the brain of human, rat and mouse. Neuroscience. 53:1993;267-295.
29. Strauss S., Bauer J., Ganter U., Jonas U., Berger M., Volk B. Detection of interleukin-6 and α2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab. Invest. 66:1992;223-229.
30. Zhan S.-S., Veerhius R., Janssen I., Kamphorst W., Eikelenboom P. Immunohistochemical distribution of the inhibitors of the terminal complement complex in Alzheimer's disease. Neurodegeneration. 3:1994;111-117.